Edition:
United States

Cytosorbents Corp (CTSO.OQ)

CTSO.OQ on NASDAQ Stock Exchange Capital Market

6.05USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$6.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
20,256
52-wk High
$7.05
52-wk Low
$3.35

Chart for

About

CytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads... (more)

Overall

Beta: -0.51
Market Cap(Mil.): $173.58
Shares Outstanding(Mil.): 28.69
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 27.83 16.04
EPS (TTM): -- -- --
ROI: -- 10.00 34.69
ROE: -- 15.21 15.46

BRIEF-Cytosorbents posts Q3 revenue of $3.8 mln

* Cytosorbents continues strong trajectory of growth in the third quarter 2017

Nov 09 2017

BRIEF-CytoSorbents says partnered with DRGR to expand sales, distribution of cytosorb to Panama

* CytoSorbents says partnered with Droguería Ramón González Revilla (DRGR) to expand sales and distribution of cytosorb to panama

Jul 17 2017

BRIEF-CytoSorbents receives additional $5 mln in non-dilutive debt financing from Bridge Bank

* CytoSorbents receives additional $5 million in non-dilutive debt financing from Bridge Bank

Jul 05 2017

Competitors

Earnings vs. Estimates